Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Organovo Holdings (ONVO)

Organovo Holdings (ONVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,341
  • Shares Outstanding, K 10,040
  • Annual Sales, $ 370 K
  • Annual Income, $ -17,260 K
  • 60-Month Beta 0.87
  • Price/Sales 37.53
  • Price/Cash Flow N/A
  • Price/Book 1.54
Trade ONVO with:

Options Overview Details

View History
  • Implied Volatility 430.06% ( -42.43%)
  • Historical Volatility 113.01%
  • IV Percentile 87%
  • IV Rank 37.29%
  • IV High 993.59% on 03/20/24
  • IV Low 94.91% on 06/15/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 94
  • Volume Avg (30-Day) 152
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 851
  • Open Int (30-Day) 1,081

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9300 +10.75%
on 05/02/24
1.7400 -40.80%
on 04/15/24
-0.0001 (-0.01%)
since 04/03/24
3-Month
0.8911 +15.59%
on 02/09/24
1.7400 -40.80%
on 04/15/24
unch (unch)
since 02/02/24
52-Week
0.8911 +15.59%
on 02/09/24
2.0500 -49.76%
on 11/07/23
-0.8300 (-44.62%)
since 05/03/23

Most Recent Stories

More News
Organovo: Fiscal Q3 Earnings Snapshot

Organovo: Fiscal Q3 Earnings Snapshot

ONVO : 1.0300 (+8.38%)
Organovo: Fiscal Q2 Earnings Snapshot

Organovo: Fiscal Q2 Earnings Snapshot

ONVO : 1.0300 (+8.38%)
Organovo Achieves 3D Tissue Model for Crohn’s Disease

SAN DIEGO, May 17, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional (3D) biology company focused on delivering...

ONVO : 1.0300 (+8.38%)
Why Organovo Holdings, Inc. Stock Soared 49.7% This Week

The company's licensing agreement with a Swedish company means an infusion of some much-needed cash for Organovo.

ONVO : 1.0300 (+8.38%)
UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents

SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO (OTCPK: CLLKF, Nasdaq Stockholm: BICO.ST) announced they...

ONVO : 1.0300 (+8.38%)
Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents

SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO today announced they have reached agreement on a broad...

ONVO : 1.0300 (+8.38%)
Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo”), today announced that it has granted a stock option to...

ONVO : 1.0300 (+8.38%)
Organovo Welcomes New Sr. Vice President of Strategy and Business Development

SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional biology company focused on delivering scientific...

ONVO : 1.0300 (+8.38%)
Organovo Guides on Patent Portfolio and Successful IPR Defense of Two Patents

SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that two of its patents have withstood a patent...

ONVO : 1.0300 (+8.38%)
Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk

SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today released its first detailed response to the lawsuit Cellink...

ONVO : 1.0300 (+8.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings,...

See More

Key Turning Points

3rd Resistance Point 1.3700
2nd Resistance Point 1.2700
1st Resistance Point 1.1500
Last Price 1.0300
1st Support Level 0.9300
2nd Support Level 0.8300
3rd Support Level 0.7100

See More

52-Week High 2.0500
Fibonacci 61.8% 1.6073
Fibonacci 50% 1.4705
Fibonacci 38.2% 1.3338
Last Price 1.0300
52-Week Low 0.8911

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar